CTI Trademark

Trademark Overview

On Tuesday, June 16, 2009, a trademark application was filed for CTI with the United States Patent and Trademark Office. The USPTO has given the CTI trademark a serial number of 77760445. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, January 13, 2020. This trademark is owned by Cell Therapeutics, Inc.. The CTI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceutical preparations; product research and development for others in the field of pharmaceutical preparations; product research and development services, namely, assessing intended target recipients of pharmaceutical preparations and positioning pharmaceutical preparations for success in clinical development and commercial use; and providing technical consultation in the field of pharmaceutical product research and development
cti

General Information

Serial Number77760445
Word MarkCTI
Filing DateTuesday, June 16, 2009
Status800 - REGISTERED AND RENEWED
Status DateMonday, January 13, 2020
Registration Number3715268
Registration DateTuesday, November 24, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2009

Trademark Statements

Goods and ServicesResearch and development of pharmaceutical preparations; product research and development for others in the field of pharmaceutical preparations; product research and development services, namely, assessing intended target recipients of pharmaceutical preparations and positioning pharmaceutical preparations for success in clinical development and commercial use; and providing technical consultation in the field of pharmaceutical product research and development
Pseudo MarkCELL THERAPEUTICS, INC.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 19, 2009
Primary Code042
First Use Anywhere DateSunday, November 30, 1997
First Use In Commerce DateSunday, November 30, 1997

Trademark Owner History

Party NameCTI BIOPHARMA CORP.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98121
Party NameCell Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119
Party NameCell Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119
Party NameCell Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Trademark Events

Event DateEvent Description
Friday, June 12, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Thursday, May 14, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 14, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 6, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 6, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 6, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 6, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 6, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, January 13, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, January 13, 2020REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, January 13, 2020REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, January 13, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 25, 2019TEAS SECTION 8 & 9 RECEIVED
Saturday, November 24, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, May 6, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 6, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 30, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, January 30, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, January 30, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 20, 2015TEAS SECTION 8 & 15 RECEIVED
Wednesday, July 2, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 24, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, September 8, 2009PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2009NOTICE OF PUBLICATION
Monday, August 3, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, August 3, 2009ASSIGNED TO LIE
Saturday, July 25, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 25, 2009ASSIGNED TO EXAMINER
Saturday, June 20, 2009NOTICE OF PSEUDO MARK MAILED
Friday, June 19, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 19, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

development pharmaceutical research preparations product field clinical success commercial consultation